Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1226

1.

Bexarotene Reduces Production of CCL22 From Tumor-Associated Macrophages in Cutaneous T-Cell Lymphoma.

Tanita K, Fujimura T, Sato Y, Lyu C, Kambayashi Y, Ogata D, Fukushima S, Miyashita A, Nakajima H, Nakamura M, Morita A, Aiba S.

Front Oncol. 2019 Sep 20;9:907. doi: 10.3389/fonc.2019.00907. eCollection 2019.

2.

Aryl Hydrocarbon Receptor Modulates Carcinogenesis and Maintenance of Skin Cancers.

Hidaka T, Fujimura T, Aiba S.

Front Med (Lausanne). 2019 Sep 4;6:194. doi: 10.3389/fmed.2019.00194. eCollection 2019. Review.

3.

Oxidative stress-responsive apoptosis inducing protein (ORAIP) plays a critical role in cerebral ischemia/reperfusion injury.

Kishimoto M, Suenaga J, Takase H, Araki K, Yao T, Fujimura T, Murayama K, Okumura K, Ueno R, Shimizu N, Kawahara N, Yamamoto T, Seko Y.

Sci Rep. 2019 Sep 18;9(1):13512. doi: 10.1038/s41598-019-50073-8.

4.

Significance of BRAF Kinase Inhibitors for Melanoma Treatment: From Bench to Bedside.

Fujimura T, Fujisawa Y, Kambayashi Y, Aiba S.

Cancers (Basel). 2019 Sep 11;11(9). pii: E1342. doi: 10.3390/cancers11091342. Review.

5.

Variable indoleamine 2,3-dioxygenase expression in acral/mucosal melanoma and its possible link to immunotherapy.

Iga N, Otsuka A, Hirata M, Kataoka TR, Irie H, Nakashima C, Matsushita S, Uchi H, Yamamoto Y, Funakoshi T, Fujisawa Y, Yoshino K, Fujimura T, Hata H, Ishida Y, Kabashima K.

Cancer Sci. 2019 Sep 11. doi: 10.1111/cas.14195. [Epub ahead of print]

6.

Influences of Maternal Factors Over Offspring Allergies and the Application for Food Allergy.

Fujimura T, Lum SZC, Nagata Y, Kawamoto S, Oyoshi MK.

Front Immunol. 2019 Aug 23;10:1933. doi: 10.3389/fimmu.2019.01933. eCollection 2019. Review.

7.

Invasion of human microvascular endothelial cells by Mycobacterium leprae through Mce1A protein.

Idris I, Abdurrahman AH, Fatulrachman, Aftitah VB, Fadlitha VB, Sato N, Fujimura T, Takimoto H.

J Dermatol. 2019 Oct;46(10):853-858. doi: 10.1111/1346-8138.15047. Epub 2019 Aug 20.

PMID:
31432529
8.

Biomarkers for Predicting Efficacies of Anti-PD1 Antibodies.

Kambayashi Y, Fujimura T, Hidaka T, Aiba S.

Front Med (Lausanne). 2019 Jul 31;6:174. doi: 10.3389/fmed.2019.00174. eCollection 2019. Review.

9.

Why Do Carbonate Anions Have Extremely High Stability in the Interlayer Space of Layered Double Hydroxides? Case Study of Layered Double Hydroxide Consisting of Mg and Al (Mg/Al = 2).

Sasai R, Sato H, Sugata M, Fujimura T, Ishihara S, Deguchi K, Ohki S, Tansho M, Shimizu T, Oita N, Numoto M, Fujii Y, Kawaguchi S, Matsuoka Y, Hagura K, Abe T, Moriyoshi C.

Inorg Chem. 2019 Aug 19;58(16):10928-10935. doi: 10.1021/acs.inorgchem.9b01365. Epub 2019 Aug 8.

PMID:
31393726
10.

Nonsense-Mediated mRNA Decay Deficiency Affects the Auxin Response and Shoot Regeneration in Arabidopsis.

Chiam NC, Fujimura T, Sano R, Akiyoshi N, Hiroyama R, Watanabe Y, Motose H, Demura T, Ohtani M.

Plant Cell Physiol. 2019 Sep 1;60(9):2000-2014. doi: 10.1093/pcp/pcz154.

PMID:
31386149
11.

Current status and future perspective of robot-assisted radical cystectomy for invasive bladder cancer.

Fujimura T.

Int J Urol. 2019 Jul 30. doi: 10.1111/iju.14076. [Epub ahead of print] Review.

PMID:
31364203
12.

Carbon 11-choline positron emission tomography/computed tomography and palliative local therapy for castration-resistant prostate cancer.

Nozaki K, Kawai T, Fujimura T, Matsui H, Teshima T, Oshina T, Takahashi A, Sato Y, Yamada D, Azuma T, Hotta M, Nakajima K, Nakayama H, Minamimoto R, Kume H.

Int Urol Nephrol. 2019 Oct;51(10):1763-1769. doi: 10.1007/s11255-019-02233-y. Epub 2019 Jul 19.

PMID:
31325132
13.

Successful Treatment of Unresectable Advanced Melanoma by Administration of Nivolumab With Ipilimumab Before Primary Tumor Resection.

Fujimura T, Kambayashi Y, Sato Y, Tanita K, Amagai R, Hashimoto A, Hidaka T, Aiba S.

Front Med (Lausanne). 2019 Jun 26;6:140. doi: 10.3389/fmed.2019.00140. eCollection 2019.

14.

Perifolliculitis capitis abscedens et suffodiens treatment with tumor necrosis factor inhibitors: A case report and review of published cases.

Takahashi T, Yamasaki K, Terui H, Omori R, Tsuchiyama K, Fujimura T, Aiba S.

J Dermatol. 2019 Sep;46(9):802-807. doi: 10.1111/1346-8138.14998. Epub 2019 Jul 4.

PMID:
31271451
15.

A novel technique to diagnose non-melanoma skin cancer by thermal conductivity measurements: Correlations with cancer stromal factors.

Fujimura T, Okabe T, Tanita K, Sato Y, Lyu C, Kambayashi Y, Maruyama S, Aiba S.

Exp Dermatol. 2019 Sep;28(9):1029-1035. doi: 10.1111/exd.13997. Epub 2019 Aug 12.

PMID:
31264287
16.

Effect of Oral Branched-Chain Amino Acids and Glutamine Supplementation on Skeletal Muscle Atrophy After Total Gastrectomy in Rat Model.

Haba Y, Fujimura T, Oyama K, Kinoshita J, Miyashita T, Fushida S, Harada S, Ohta T.

J Surg Res. 2019 Nov;243:281-288. doi: 10.1016/j.jss.2019.05.041. Epub 2019 Jun 26.

PMID:
31254901
17.

Roles of the hexosamine biosynthetic pathway and pentose phosphate pathway in bile acid-induced cancer development.

Munemoto M, Mukaisho KI, Miyashita T, Oyama K, Haba Y, Okamoto K, Kinoshita J, Ninomiya I, Fushida S, Taniura N, Sugihara H, Fujimura T.

Cancer Sci. 2019 Aug;110(8):2408-2420. doi: 10.1111/cas.14105. Epub 2019 Jul 23.

18.

Robot-assisted radical prostatectomy versus volumetric modulated arc therapy: Comparison of front-line therapies for localized prostate cancer.

Taguchi S, Shiraishi K, Fujimura T, Naito A, Kawai T, Nakagawa K, Abe O, Kume H, Fukuhara H.

Radiother Oncol. 2019 Jun 5;140:62-67. doi: 10.1016/j.radonc.2019.05.015. [Epub ahead of print]

PMID:
31176208
19.

Addition of a β1-Blocker to Milrinone Treatment Improves Cardiac Function in Patients with Acute Heart Failure and Rapid Atrial Fibrillation.

Kobayashi S, Myoren T, Kajii T, Kohno M, Nanno T, Ishiguchi H, Nishimura S, Fukuda M, Hino A, Fujimura T, Ono M, Uchinoumi H, Tateishi H, Mochizuki M, Oda T, Okuda S, Yoshiga Y, Kawano R, Yano M.

Cardiology. 2019;142(4):195-202. doi: 10.1159/000499400. Epub 2019 May 28.

20.

Living Donor Liver Re-Transplantation for Recurrent Hepatoblastoma in the Liver Graft following Complete Eradication of Peritoneal Metastases under Indocyanine Green Fluorescence Imaging.

Takahashi N, Yamada Y, Hoshino K, Kawaida M, Mori T, Abe K, Fujimura T, Matsubara K, Hibi T, Shinoda M, Obara H, Isshiki K, Shima H, Shimada H, Kameyama K, Fuchimoto Y, Kitagawa Y, Kuroda T.

Cancers (Basel). 2019 May 26;11(5). pii: E730. doi: 10.3390/cancers11050730.

21.

Association of Baseline Serum Levels of CXCL5 With the Efficacy of Nivolumab in Advanced Melanoma.

Fujimura T, Sato Y, Tanita K, Lyu C, Kambayashi Y, Amagai R, Otsuka A, Fujisawa Y, Yoshino K, Matsushita S, Uchi H, Yamamoto Y, Hata H, Funakoshi T, Nonomura Y, Tanaka R, Okuhira H, Wada N, Hashimoto A, Aiba S.

Front Med (Lausanne). 2019 Apr 26;6:86. doi: 10.3389/fmed.2019.00086. eCollection 2019.

22.

Lichen planus pemphigoides developing from patient with non-small-cell lung cancer treated with nivolumab.

Sato Y, Fujimura T, Mizuashi M, Aiba S.

J Dermatol. 2019 Oct;46(10):e374-e375. doi: 10.1111/1346-8138.14906. Epub 2019 May 7. No abstract available.

PMID:
31062404
23.

Colon perforation due to antigenemia-negative cytomegalovirus gastroenteritis after liver transplantation: A case report and review of literature.

Yokose T, Obara H, Shinoda M, Nakano Y, Kitago M, Yagi H, Abe Y, Yamada Y, Matsubara K, Oshima G, Hori S, Ibuki S, Higashi H, Masuda Y, Hayashi M, Mori T, Kawaida M, Fujimura T, Hoshino K, Kameyama K, Kuroda T, Kitagawa Y.

World J Gastroenterol. 2019 Apr 21;25(15):1899-1906. doi: 10.3748/wjg.v25.i15.1899. Review.

24.

Successful treatment of multiple eruptive adult xanthogranuloma concomitant with xanthelasma palpebrarum with probucol.

Ishihara-Yusa S, Fujimura T, Lyu C, Sugawara M, Sakamoto K, Aiba S.

J Dermatol. 2019 Oct;46(10):e362-e364. doi: 10.1111/1346-8138.14903. Epub 2019 May 3. No abstract available.

PMID:
31050040
25.

Classification of 3097 patients from the Japanese melanoma study database using the American joint committee on cancer eighth edition cancer staging system.

Fujisawa Y, Yoshikawa S, Minagawa A, Takenouchi T, Yokota K, Uchi H, Noma N, Nakamura Y, Asai J, Kato J, Fujiwara S, Fukushima S, Uehara J, Hoashi T, Kaji T, Fujimura T, Namikawa K, Yoshioka M, Murata N, Ogata D, Matsuyama K, Hatta N, Shibayama Y, Fujiyama T, Ishikawa M, Yamada D, Kishi A, Nakamura Y, Shimiauchi T, Fujii K, Fujimoto M, Ihn H, Katoh N.

J Dermatol Sci. 2019 May;94(2):284-289. doi: 10.1016/j.jdermsci.2019.04.003. Epub 2019 Apr 17.

PMID:
31023613
26.

Malassezia-derived aryl hydrocarbon receptor ligands enhance the CCL20/Th17/soluble CD163 pathogenic axis in extra-mammary Paget's disease.

Sato Y, Fujimura T, Tanita K, Chunbing L, Matsushita S, Fujisawa Y, Otsuka A, Yamamoto Y, Hidaka T, Aiba S.

Exp Dermatol. 2019 Aug;28(8):933-939. doi: 10.1111/exd.13944. Epub 2019 Jun 6.

PMID:
31001887
27.

Longitudinal change of comprehensive lower urinary tract symptoms and various types of urinary incontinence during robot-assisted radical prostatectomy.

Fujimura T, Igawa Y, Aizawa N, Niimi A, Yamada Y, Sugihara T, Kamei J, Sato Y, Matsunaga A, Yoshida M, Shinoda Y, Fukuhara H, Nakagawa T, Homma Y, Kume H.

Neurourol Urodyn. 2019 Apr;38(4):1067-1075. doi: 10.1002/nau.23952. Epub 2019 Mar 14.

PMID:
30995359
28.

Which types of clay minerals fix cesium ions effectively? the "cavity-charge matching effect".

Yamamoto T, Takigawa T, Fujimura T, Shimada T, Ishida T, Inoue H, Takagi S.

Phys Chem Chem Phys. 2019 May 8;21(18):9352-9356. doi: 10.1039/c9cp00457b.

PMID:
30994658
29.

Clinical and histopathological characteristics and survival analysis of 4594 Japanese patients with melanoma.

Fujisawa Y, Yoshikawa S, Minagawa A, Takenouchi T, Yokota K, Uchi H, Noma N, Nakamura Y, Asai J, Kato J, Fujiwara S, Fukushima S, Uehara J, Hoashi T, Kaji T, Fujimura T, Namikawa K, Yoshioka M, Murao N, Ogata D, Matsuyama K, Hatta N, Shibayama Y, Fujiyama T, Ishikawa M, Yamada D, Kishi A, Nakamura Y, Shimiauchi T, Fujii K, Fujimoto M, Ihn H, Katoh N.

Cancer Med. 2019 May;8(5):2146-2156. doi: 10.1002/cam4.2110. Epub 2019 Apr 1.

30.

Three cases of nivolumab therapy-failed advanced melanoma successfully controlled by ipilimumab with intensity-modulated radiotherapy.

Amagai R, Fujimura T, Kambayashi Y, Sato Y, Tanita K, Hashimoto A, Aiba S.

J Dermatol. 2019 May;46(5):449-452. doi: 10.1111/1346-8138.14861. Epub 2019 Mar 25.

PMID:
30908705
31.

Efficacy of the proximal optimization technique on crossover stenting in coronary bifurcation lesions in the 3D-OCT bifurcation registry.

Murasato Y, Mori T, Okamura T, Nagoshi R, Fujimura T, Yamawaki M, Ono S, Serikawa T, Nakao F, Shite J; 3D-OCT Bifurcation Registry Investigators.

Int J Cardiovasc Imaging. 2019 Jun;35(6):981-990. doi: 10.1007/s10554-019-01581-1. Epub 2019 Mar 18.

PMID:
30887408
32.

Effects of Dietary Supplementation With Enterococcus faecium and Clostridium butyricum, Either Alone or in Combination, on Growth and Fecal Microbiota Composition of Post-weaning Pigs at a Commercial Farm.

Sato Y, Kuroki Y, Oka K, Takahashi M, Rao S, Sukegawa S, Fujimura T.

Front Vet Sci. 2019 Feb 28;6:26. doi: 10.3389/fvets.2019.00026. eCollection 2019.

33.

Molecular Taxonomy of Interstitial Cystitis/Bladder Pain Syndrome Based on Whole Transcriptome Profiling by Next-Generation RNA Sequencing of Bladder Mucosal Biopsies.

Akiyama Y, Maeda D, Katoh H, Morikawa T, Niimi A, Nomiya A, Sato Y, Kawai T, Goto A, Fujimura T, Fukuhara H, Nakagawa T, Igawa Y, Ishikawa S, Fukayama M, Kume H, Homma Y.

J Urol. 2019 Aug;202(2):290-300. doi: 10.1097/JU.0000000000000234. Epub 2019 Jul 8.

PMID:
30865573
34.

First-in-human clinical study of novel technique to diagnose malignant melanoma via thermal conductivity measurements.

Okabe T, Fujimura T, Okajima J, Kambayashi Y, Aiba S, Maruyama S.

Sci Rep. 2019 Mar 7;9(1):3853. doi: 10.1038/s41598-019-40444-6.

35.

The unique tropism of Mycobacterium leprae to the nasal epithelial cells can be explained by the mammalian cell entry protein 1A.

Fadlitha VB, Yamamoto F, Idris I, Dahlan H, Sato N, Aftitah VB, Febriyanda A, Fujimura T, Takimoto H.

PLoS Negl Trop Dis. 2019 Mar 5;13(3):e0006704. doi: 10.1371/journal.pntd.0006704. eCollection 2019 Mar.

36.

Anticancer effect of nor-wogonin (5, 7, 8-trihydroxyflavone) on human triple-negative breast cancer cells via downregulation of TAK1, NF-κB, and STAT3.

Abd El-Hafeez AA, Khalifa HO, Mahdy EAM, Sharma V, Hosoi T, Ghosh P, Ozawa K, Montano MM, Fujimura T, Ibrahim ARN, Abdelhamid MAA, Pack SP, Shouman SA, Kawamoto S.

Pharmacol Rep. 2019 Apr;71(2):289-298. doi: 10.1016/j.pharep.2019.01.001. Epub 2019 Jan 7.

37.

[A Case of Type 4 Ascending Colon Cancer Showing Early Postoperative Lymphangitis Carcinomatosa].

Katano K, Kurata T, Hagino S, Shoji Y, Sasaki S, Terada I, Yoshikawa A, Kitagawa H, Fujimura T.

Gan To Kagaku Ryoho. 2019 Jan;46(1):139-141. Japanese.

PMID:
30765667
38.

The effectiveness of transoral marsupialization for lingual thyroglossal duct cysts - Twelve successfully treated cases at a single institution.

Harumatsu T, Uchida G, Fujimura T, Kato M, Tomita H, Ishioka S, Shimotakahara A, Shimojima N, Ieiri S, Hirobe S.

J Pediatr Surg. 2019 Apr;54(4):766-770. doi: 10.1016/j.jpedsurg.2018.12.009. Epub 2019 Jan 23.

PMID:
30732933
39.

Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis.

Maruyama H, Miyata K, Mikame M, Taguchi A, Guili C, Shimura M, Murayama K, Inoue T, Yamamoto S, Sugimura K, Tamita K, Kawasaki T, Kajihara J, Onishi A, Sugiyama H, Sakai T, Murata I, Oda T, Toyoda S, Hanawa K, Fujimura T, Ura S, Matsumura M, Takano H, Yamashita S, Matsukura G, Tazawa R, Shiga T, Ebato M, Satoh H, Ishii S.

Genet Med. 2019 May;21(5):1263. doi: 10.1038/s41436-019-0447-8.

PMID:
30728527
40.

Efficacy and safety of sirolimus treatment for intractable lymphatic anomalies: A study protocol for an open-label, single-arm, multicenter, prospective study (SILA).

Ozeki M, Asada R, Saito AM, Hashimoto H, Fujimura T, Kuroda T, Ueno S, Watanabe S, Nosaka S, Miyasaka M, Umezawa A, Matsuoka K, Maekawa T, Yamada Y, Fujino A, Hirakawa S, Furukawa T, Tajiri T, Kinoshita Y, Souzaki R, Fukao T.

Regen Ther. 2019 Jan 14;10:84-91. doi: 10.1016/j.reth.2018.12.001. eCollection 2019 Jun.

41.

[A Case of Type 4 Gastric Cancer with Esophageal Invasion That Responded to Neoadjuvant Chemotherapy Containing S-1 and Oxaliplatin followed by Surgery].

Hagino S, Fujimura T, Kurata T, Shoji Y, Sasaki S, Terada I, Yoshikawa A, Kitagawa H, Izumi R, Saito K.

Gan To Kagaku Ryoho. 2018 Dec;45(13):2327-2329. Japanese.

PMID:
30692453
42.

CD30-Positive Angioinvasive Lymphomatoid Papulosis (Type E) Developing from Parapsoriasis en Plaque.

Fujimura T, Lyu C, Tsuchiyama K, Aiba S.

Case Rep Oncol. 2018 Dec 13;11(3):850-854. doi: 10.1159/000495689. eCollection 2018 Sep-Dec.

43.

Accumulation of exhausted CD8+ T cells in extramammary Paget's disease.

Iga N, Otsuka A, Yamamoto Y, Nakashima C, Honda T, Kitoh A, Nakajima S, Egawa G, Nomura T, Dainichi T, Matsushita S, Tanizaki H, Yamamoto Y, Funakoshi T, Fujisawa Y, Fujimura T, Hata H, Ishida Y, Kabashima K.

PLoS One. 2019 Jan 25;14(1):e0211135. doi: 10.1371/journal.pone.0211135. eCollection 2019.

44.

Successful treatment of unresectable recurrent programmed death ligand 1 moderately-expressing malignant melanoma of the nasal cavity with pembrolizumab monotherapy.

Fujimura T, Kambayashi Y, Sato Y, Tanita K, Tono H, Lyu C, Takahashi T, Hashimoto A, Aiba S.

J Dermatol. 2019 Jul;46(7):e260. doi: 10.1111/1346-8138.14786. Epub 2019 Jan 23. No abstract available.

PMID:
30672615
45.

Successful treatment of microcystic adnexal carcinoma on the philtrum with oral S-1 monotherapy.

Haga T, Fujimura T, Aiba S.

J Dermatol. 2019 Jun;46(6):e208-e209. doi: 10.1111/1346-8138.14770. Epub 2019 Jan 21. No abstract available.

PMID:
30663155
46.

Pembrolizumab resolves adult ashy dermatosis developing in patients with squamous cell carcinoma of the lung.

Takeda K, Fujimura T, Tsuchiyama K, Lyu C, Aiba S.

J Dermatol. 2019 Mar;46(3):271-273. doi: 10.1111/1346-8138.14775. Epub 2019 Jan 21.

PMID:
30663147
47.

Molecular targeting of HER2-overexpressing biliary tract cancer cells with trastuzumab emtansine, an antibody-cytotoxic drug conjugate.

Yamashita-Kashima Y, Yoshimura Y, Fujimura T, Shu S, Yanagisawa M, Yorozu K, Furugaki K, Higuchi R, Shoda J, Harada N.

Cancer Chemother Pharmacol. 2019 Apr;83(4):659-671. doi: 10.1007/s00280-019-03768-8. Epub 2019 Jan 18.

PMID:
30659304
48.

Severe rhabdomyolysis developing in an advanced melanoma patient treated by pembrolizumab followed by dabrafenib trametinib combined therapy.

Irimada M, Fujimura T, Kambayashi Y, Tsukada A, Takahashi T, Hashimoto A, Aiba S.

J Dermatol. 2019 Jul;46(7):e256-e258. doi: 10.1111/1346-8138.14778. Epub 2019 Jan 18. No abstract available.

PMID:
30656733
49.

Laparoscopic Partial Closure for Congenital Portosystemic Shunt-Indications, Postoperative Management, and Subsequent Complete Closure.

Mori T, Yamada Y, Abe K, Takahashi N, Kano M, Fujimura T, Watanabe T, Nakatsuka S, Hoshino K, Kuroda T.

J Laparoendosc Adv Surg Tech A. 2019 Apr;29(4):573-578. doi: 10.1089/lap.2018.0581. Epub 2019 Jan 7.

PMID:
30614751
50.

BRAF kinase inhibitors for treatment of melanoma: developments from early-stage animal studies to Phase II clinical trials.

Fujimura T, Hidaka T, Kambayashi Y, Aiba S.

Expert Opin Investig Drugs. 2019 Feb;28(2):143-148. doi: 10.1080/13543784.2019.1558442. Epub 2018 Dec 16. Review.

PMID:
30556435

Supplemental Content

Loading ...
Support Center